Media Update, page-1401

I would quickly like to emphasis that 'yes, my position is down in AT1 atm' but in no way am I bleeding or concerned where the SP currently sits. In fact, I'm quietly confident in the medium term prospects for RDT as an industry in general and that I had purchased more shares last Thursday on this sentiment.

I'm simply frustrated with glacial speed at which the TGA is taking to assess an application for a test that's already proven to be safe and performs an 'acceptable sensitivity' level for the detection of COVID. Especially at a time when we most need these medical devices to be readily available. I don't see this as an efficient tool in safeguarding the interest of Australians where the TGA can not cross reference information on efficacy of an already approved device when assessing a new application on the same device. That's it in a nutshell.